Medical devicemaker Medtronic saw nearly $8.1 billion in revenue in its third quarter of fiscal year 2024, a 4.7% increase from the year earlier.
In the three months ending Jan. 26, Medtronic recorded $8.09 billion in net sales. The growth from a year ago, which reported $7.73 billion in revenue, is attributed to Medtronic's diabetes, core spine, cardiac surgery, structural heart and cardiac pacing services.